| Name | Ibrutinib-MPEA | 
|---|
| Description | Ibrutinib-MPEA (Compound 20) is ibrutinib derivative. Ibrutinib is a covalent and irreversible inhibitor of Bruton's tyrosine kinase (BTK) that has been used to treat haematological malignancies[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Molecular Formula | C32H39N9O2 | 
|---|---|
| Molecular Weight | 581.71 |